Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tmu-ACR-16-like is a nicotinic acetylcholine receptor (nAChR) subunit identified in the mouse whipworm, Trichuris muris, which serves as a laboratory model for the human parasite Trichuris trichiura [2, 3]. This subunit assembles into a functional homomeric ion channel, often referred to as the oxantel-sensitive acetylcholine receptor (O-AChR), which plays a vital role in the parasite's neuromuscular transmission and motility [5, 7]. It is a primary therapeutic target for the anthelmintic drug oxantel, which acts as a potent agonist, leading to persistent depolarization, muscle contraction, and eventual paralysis of the worm [2, 5]. Notably, Tmu-ACR-16-like displays a distinct pharmacological profile compared to other nematode nAChRs, as it is highly sensitive to oxantel and epibatidine but notably insensitive to pyrantel [2, 7]. Research into this receptor provides critical insights into the species-specific drug responses of whipworms and aids in the optimization of treatments for soil-transmitted helminthiasis [3, 6].
Agonist
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic acetylcholine receptor subunit ACR-16-like (Tmu-ACR-16-like).